Real-World Evidence (RWE) is seen by many as the healthcare industry's valuable new currency. Decision-makers are increasingly using RWE to inform decisions about the cost effectiveness and patient value of a new product. In response, companies are starting to not only assess products in traditional randomized controlled trials, but also in real-world programs, in which patients take the medicine in real-life environments, to collect Real-World Data (RWD).
Our latest eBook describes what RWD is and how it feeds into RWE, as well as exploring the growing influence of the patient voice and how it can provide richer insights into the effectiveness of new drugs compared to traditional clinical trials alone.
To find out more, simply fill in the short form and download the eBook.